[{"from": "human", "value": "Could you provide a description of this molecule? [C][C][=Branch1][C][=O][N][C][=C][Branch2][Ring1][N][C][=Branch1][P][=C][Branch1][=N][C][=Branch1][Branch1][=C][Ring1][=Branch1][I][C][=Branch1][C][=O][O][I][C][=Branch1][C][=O][N][C][C][O][I]"}, {"from": "gpt", "value": "The molecule is an ionic iodinated contrast medium. It is a first-generation contrast media formed by an ionic monomer with a high osmolarity of 1500-1800 mOsm/kg. Ioxitalamic acid in the salt forms of sodium and meglumine was developed by Liebel-Flarshem Canada Inc and approved by Health Canada in 1995. Until the last review in 2015, this drug is still available in the market."}]